Clinical Trial Update: Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced target delineation and radiation doses with chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Xiayun He, MD | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED